CLINICAL TRIAL

Text message reminder for Human Papillomavirus Vaccination

Recruiting · < 18 · Female · Kampala, Uganda

SMS HPV Vaccine Reminders

See full description

About the trial for Human Papillomavirus Vaccination

Treatment Groups

This trial involves 2 different treatments. Text Message Reminder is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Main TreatmentA portion of participants receive this new treatment to see if it outperforms the control.
Text message reminder
BEHAVIORAL
Control TreatmentAnother portion of participants receive the standard treatment to act as a baseline.

About The Treatment

Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Text message reminder
2012
N/A
~730

Eligibility

This trial is for female patients aged 18 and younger. There are 5 eligibility criteria to participate in this trial as listed below.

Inclusion & Exclusion Checklist
Mark “yes” if the following statements are true for you:
old If you are a parenting adult of an adolescent girl aged 10-14 years old, it is important to remember that during this time, your daughter is going through a lot of changes show original
Must be able to consent in order to have sexual activity. show original
If you want to talk to someone, please speak English or Luganda show original
Have a cell phone with text messaging capability
I live in Kampala and its surrounding districts. show original
View All
Odds of Eligibility
Unknown<50%
Be sure to apply to 2-3 other trials, as you have a low likelihood of qualifying for this one.Apply To This Trial

Approximate Timelines

Please note that timelines for treatment and screening will vary by patient
Screening: ~3 weeks
Treatment: varies
Reporting: Up to 6 months from randomization
Screening: ~3 weeks
Treatment: Varies
Reporting: Up to 6 months from randomization
This trial has approximate timelines as follows: 3 weeks for initial screening, variable treatment timelines, and reporting: Up to 6 months from randomization.
View detailed reporting requirements
Trial Expert
Connect with the researchersHop on a 15 minute call & ask questions about:
- What options you have available- The pros & cons of this trial
- Whether you're likely to qualify- What the enrollment process looks like

Measurement Requirements

This trial is evaluating whether Text message reminder will improve 1 primary outcome in patients with Human Papillomavirus Vaccination. Measurement will happen over the course of Up to 6 months from randomization.

Time to Receipt of Next HPV Vaccine Dose
UP TO 6 MONTHS FROM RANDOMIZATION
Timeliness of vaccination (time to event) will be measured.
UP TO 6 MONTHS FROM RANDOMIZATION

Who is running the study

Principal Investigator
M. S.
Prof. Melissa Stockwell, Associate Professor of Pediatrics and Population and Family Health
Columbia University

Patient Q & A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What causes human papillomavirus vaccination?

The health benefits of vaccination for HPV are well accepted, but knowledge is lacking on why children have not received their vaccination. We found this by examining factors contributing to not receiving the vaccine. This information will inform the design of effective and cost-effective interventions to increase HPV vaccination rates worldwide.

Anonymous Patient Answer

What is human papillomavirus vaccination?

HPV-vaccination is not routinely advised in the USA for young girls and women aged 11–21 years. More information on the vaccine is needed to increase vaccination rates among adolescents.

Anonymous Patient Answer

What are common treatments for human papillomavirus vaccination?

The use of HPV vaccine decreases the high rates of cervical cancer. This treatment is highly effective in adolescents and young adult women aged 13 to 24 years. There are no vaccine contraindications, and there are no adverse effects after the HPV vaccination. HPV vaccination is administered safely and is effective for those ages 13 to 24 years.

Anonymous Patient Answer

What are the signs of human papillomavirus vaccination?

For HPV-positive adolescents, sexual contact and non-vaccination related signs were common. For HPV-negative adolescents, vaccination-related signs were more common. Screened children should be counseled regarding possible health complaints that may occur in the short term.

Anonymous Patient Answer

How many people get human papillomavirus vaccination a year in the United States?

A substantial proportion of adolescents do not receive HPV vaccinations. Most adolescents who do not get HPV vaccinations have never been to the dentist and have not received an update on their vaccination status during any clinical visit.

Anonymous Patient Answer

Can human papillomavirus vaccination be cured?

Vaccine-induced IgG antibody formation appears to be an important factor determinant of the persistence of anti-Vp125 antibodies for a long period of time in patients vaccinated with the vaccine.

Anonymous Patient Answer

What are the latest developments in text message reminder for therapeutic use?

Therapeutic reminders are feasible, cost-effective, and have a small effect on clinical activity. The text message approach should be evaluated in a larger study of a more diverse patient population.

Anonymous Patient Answer

How serious can human papillomavirus vaccination be?

In the Netherlands, HPV vaccination seems to be as safe as in other Western countries. There is currently very limited evidence for an association with increased risk of anal cancer. There may also be a decrease in the risk of cervical cancer, but this needs confirmation.

Anonymous Patient Answer

Does human papillomavirus vaccination run in families?

While HPV vaccine does not appear to run in families, these findings raise the possibility of an interaction between vaccine variables and host factors, such as genetic susceptibility. Further family-based analysis is warranted.

Anonymous Patient Answer

What are the common side effects of text message reminder?

In a recent study, findings of this study provide an accurate description of common text message side effects and will help clinicians to more effectively assess and treat the patients with text message, not only the vaccination for HPV, but also to other possible side effects of mHealth.

Anonymous Patient Answer

Who should consider clinical trials for human papillomavirus vaccination?

The authors of 2 recent systematic review articles identified patients who should consider clinical trials to support their decision to receive HPV vaccine. Further research to identify and characterize these patients is needed to develop more effective approaches to support individuals making their treatment decisions.

Anonymous Patient Answer

What is the average age someone gets human papillomavirus vaccination?

Data from a recent study population, the average age of participants was 40.8 years. Data from a recent study suggest that younger women have a higher rate of [cervical cancer](https://www.withpower.com/clinical-trials/cervical-cancer) incidence from cervical cancer-related human papillomavirus infection and that younger men may have a higher risk of developing penile cancer as a result of human papillomavirus-induced sexual promiscuity.

Anonymous Patient Answer
See if you qualify for this trial
Get access to this novel treatment for Human Papillomavirus Vaccination by sharing your contact details with the study coordinator.